Takeda Pharmaceutical (4502.T) Return on Assets (ROA)

Price: $4552
Market Cap: $7.22T
Avg Volume: 4.08M
Country: JP
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Beta: 0.414
52W Range: $3852-4573
Website: Takeda Pharmaceutical

Takeda Pharmaceutical Return on Assets (ROA) Summary

Takeda Pharmaceutical's ROA indicates the return generated on the company's assets:

  • Annual: 0.95%
  • Quarterly: 0.16%
  • TTM: 1.38%

What is Return on Assets (ROA)?

Return on Assets (ROA) is a financial ratio that shows the percentage of profit a company earns in relation to its overall resources. It is an indicator of how efficiently a company is using its assets to generate earnings.

Related Metrics

Other important metrics to assess Takeda Pharmaceutical's profitability include:

  • ROE (Return on Equity) - measures the return generated on shareholders' equity:
    • Annual: 1.98%
    • Quarterly: 0.32%
    • TTM: 2.83%
  • ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
    • Annual: 4.44%
    • Quarterly: 0.46%
    • TTM: 3.17%
  • Return on Tangible Assets - measures the return generated on the company's tangible assets:
    • Annual: 2.66%
    • Quarterly: 0.42%
    • TTM: 3.69%
  • Profit Margin - shows the percentage of revenue that has turned into profit:
    • Annual: 3.38%
    • Quarterly: 2.08%
    • TTM: 4.54%

These metrics provide insights into Takeda Pharmaceutical's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROA

0.95%

Quarterly ROA

0.16%

TTM ROA

1.38%

Takeda Pharmaceutical Historical ROA
4.55%4.55%2.96%2.96%1.37%1.37%-0.22%-0.22%-1.80%-1.80%-3.39%-3.39%ROA201620162017201720182018201920192020202020212021202220222023202320242024
Historical ROE
9.36%9.36%6.12%6.12%2.89%2.89%-0.35%-0.35%-3.59%-3.59%-6.82%-6.82%ROE201620162017201720182018201920192020202020212021202220222023202320242024
Historical ROIC
6.17%6.17%4.18%4.18%2.20%2.20%0.21%0.21%-1.77%-1.77%-3.76%-3.76%ROIC201620162017201720182018201920192020202020212021202220222023202320242024
Historical Profit Margin
11.76%11.76%7.77%7.77%3.78%3.78%-0.22%-0.22%-4.21%-4.21%-8.20%-8.20%Profit Margin201620162017201720182018201920192020202020212021202220222023202320242024
Historical Return on Tangible Assets
9.06%9.06%6.10%6.10%3.14%3.14%0.17%0.17%-2.79%-2.79%-5.75%-5.75%Return on Tangible Assets201620162017201720182018201920192020202020212021202220222023202320242024

Takeda Pharmaceutical Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.

Year ROA ROE ROIC Profit Margin Return on Tangible Assets
2024 0.95% 1.98% 4.44% 3.38% 2.66%
2023 2.27% 4.99% 3.49% 7.87% 6.47%
2022 1.75% 4.05% 3.11% 6.45% 4.65%
2021 2.91% 7.27% 4.67% 11.76% 7.57%
2020 0.35% 0.94% -0.65% 1.34% 0.95%
2019 0.79% 2.12% 1.91% 5.20% 2.25%
2018 4.55% 9.36% 6.17% 10.56% 9.06%
2017 2.64% 6.07% 3.55% 6.64% 5.07%
2016 2.10% 4.11% 2.83% 4.44% 3.48%
2015 -3.39% -6.82% -3.76% -8.20% -5.75%

Related Metrics

Explore detailed financial metrics and analysis for 4502.T.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio